news 1 month ago

FDA Approves Remdesivir to Treat COVID-19

Wibbitz - News
FDA Approves Remdesivir to Treat COVID-19. U.S. regulators have approved the use of remdesivir, an antiviral medicine, for COVID-19 treatment. . It is officially the first drug to win full approval for COVID-19 treatment from the Food and Drug Administration (FDA). The drug, otherwise known as Veklury by Gilead Sciences Inc., reportedly cuts COVID-19 recovery time down from 15 days to 10. . Those results were found in a large study led by the U.S. National Institutes of Health. . However, a study conducted by the World Health Organization found that the drug did not help hospitalized COVID-19 patients. . Nevertheless, the drug has been authorized for emergency use since the spring. . President Donald Trump even received it when he was hospitalized with COVID-19 earlier this month. Gilead is charging $2,340 for a typical treatment course for those covered by government health programs. For those with private insurance, the cost of treatment is $3,120. Out-of-pocket payments depend on a person’s insurance, income and other factors.